HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joan Perelló Selected Research

Phytic Acid (Inositol Hexaphosphate)

10/2019Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis.
1/2018SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels.
1/2015Relationship between Urinary Level of Phytate and Valvular Calcification in an Elderly Population: A Cross-Sectional Study.
3/2013Protective effect of myo-inositol hexaphosphate (phytate) on bone mass loss in postmenopausal women.
12/2010Effect of tetracalcium dimagnesium phytate on bone characteristics in ovariectomized rats.
7/2007Effect of crystallization inhibitors on vascular calcifications induced by vitamin D: a pilot study in Sprague-Dawley rats.
4/2005Study of the absorption of myo-inositol hexakisphosphate (InsP6) through the skin.
1/2005Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joan Perelló Research Topics

Disease

6Kidney Calculi (Kidney Stone)
07/2009 - 08/2002
5Calciphylaxis
01/2022 - 01/2018
5Vascular Calcification
01/2022 - 07/2007
5Calculi (Calculus)
11/2011 - 01/2005
3Chronic Kidney Failure (Chronic Renal Failure)
01/2021 - 01/2018
3Bone Resorption
07/2015 - 12/2010
3Osteoporosis
03/2013 - 07/2007
2Wounds and Injuries (Trauma)
01/2022 - 10/2019
2Pain (Aches)
01/2022 - 10/2019
2Diabetes Mellitus
01/2021 - 12/2020
2Shock
07/2009 - 01/2005
1Cardiovascular Diseases (Cardiovascular Disease)
12/2020
1Infections
10/2019
1Hypercholesterolemia
01/2015
1Osteoporotic Fractures
03/2013
1Postmenopausal Osteoporosis
12/2010
1Hypercalciuria
07/2009
1Calcinosis
07/2007
1Calcinosis Cutis
04/2005
1Premature Aging
04/2005
1Neoplasms (Cancer)
08/2002

Drug/Important Bio-Agent (IBA)

8Phytic Acid (Inositol Hexaphosphate)IBA
10/2019 - 01/2005
7SNF472IBA
01/2022 - 01/2018
5Calcium OxalateIBA
07/2009 - 01/2005
4CalciumIBA
01/2021 - 11/2011
4Diphosphonates (Bisphosphonates)IBA
07/2015 - 07/2007
3Uric Acid (Urate)IBA
01/2007 - 09/2005
2Vitamin DFDA LinkGeneric
12/2020 - 07/2007
2calcium phosphateIBA
10/2020 - 07/2009
2Durapatite (Hydroxylapatite)IBA
10/2019 - 03/2006
1SodiumIBA
01/2022
1Analgesics (Analgesic Drugs)IBA
01/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2020
1Phosphates (Orthophosphate)IBA
12/2020
1Warfarin (Coumadin)FDA LinkGeneric
12/2020
1SaltsIBA
01/2018
1Zoledronic Acid (Zometa)FDA Link
07/2015
1Risedronic Acid (Actonel)FDA LinkGeneric
07/2015
1NitrogenIBA
07/2015
1Messenger RNA (mRNA)IBA
01/2012
1deoxypyridinolineIBA
12/2010
1OsteocalcinIBA
12/2010
1dihydrate dibasic calcium phosphate (brushite)IBA
07/2009
1PolyphosphatesIBA
07/2007
1Etidronic Acid (HEDP)FDA LinkGeneric
07/2007
1Biological ProductsIBA
07/2007
1diphosphoric acid (pyrophosphoric acid)IBA
01/2005
1Citric Acid (Citrate)FDA LinkGeneric
01/2005
1CholesterolIBA
08/2002

Therapy/Procedure

5Renal Dialysis (Hemodialysis)
01/2021 - 01/2018
3Therapeutics
10/2020 - 01/2018
2Lithotripsy (Extracorporeal Shockwave Lithotripsy)
07/2009 - 01/2005
1Subcutaneous Injections
07/2007